Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Tisagenlecleucel (Synonyms: CTL019)

Catalog No. T80981 Copy Product Info
🥰Excellent
Tisagenlecleucel (CTL019), an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy, selectively targets and eradicates CD19-expressing B cells, and is utilized in the study of refractory aggressive diffuse large B-cell lymphoma [1] [2].

Tisagenlecleucel

Copy Product Info
🥰Excellent
Catalog No. T80981
Synonyms CTL019

Tisagenlecleucel (CTL019), an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy, selectively targets and eradicates CD19-expressing B cells, and is utilized in the study of refractory aggressive diffuse large B-cell lymphoma [1] [2].

Tisagenlecleucel
Cas No. 1823078-37-0
Pack SizePriceUSA StockGlobal StockQuantity
5 mgInquiryInquiryInquiry
50 mgInquiryInquiryInquiry
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Tisagenlecleucel (CTL019), an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy, selectively targets and eradicates CD19-expressing B cells, and is utilized in the study of refractory aggressive diffuse large B-cell lymphoma [1] [2].
In vivo
Tisagenlecleucel targets and eliminates B cells expressing CD19, demonstrating efficacy against B-cell lymphoma [1].
SynonymsCTL019
Chemical Properties
Cas No.1823078-37-0
Storage & Solubility Information
Storage-20°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Citations

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy Tisagenlecleucel | purchase Tisagenlecleucel | Tisagenlecleucel cost | order Tisagenlecleucel | Tisagenlecleucel in vivo